Angel and Seed Funds
Angel and Seed Funds
An angel group or seed fund will help provide capital for an early stage (often pre-revenue) company, usually in exchange for convertible debt or ownership equity.
An angel group or seed fund will help provide capital for an early stage (often pre-revenue) company, usually in exchange for convertible debt or ownership equity.
Co-convened by the Duke-Margolis Institute for Health Policy and the U.S. FDA CDER Center for Clinical Trial Innovation (C3TI), this workshop will explore progress in clinical trial innovation to improve the efficiency of drug development.
The in-person event takes place from 9am to 4:30pm in Washington, DC, and, on the West Coast, the webinar runs from 6am to 1:30pm (both in Daylight Savings time).
We willl highlight C3TI’s activities and emerging priorities and review lessons learned from recent efforts, the benefits of adopting innovative approaches in clinical trials, and persistent challenges. In addition, attendees will discuss strategies to bridge from policy to implementation to broader adoption of innovative approaches in the design and conduct of clinical trials.
There is no cost to participate but registration is required.
For more information, including registration, the draft workshop agenda as it develops and more, visit the Duke Margolis Institute for Health Policy event landing page.